We are excited to announce the formal launch of Alberti Lim & Tonkovich LLP’s Pharmaceutical and Life Sciences Practice Group co-chaired by partners Dr. Russ Tonkovich in California and Jim Barabas in the New York City/New Jersey tri-state area.

The team members’ backgrounds are in medicine, biochemistry, and chemistry, and they have extensive experience in the field, having litigated across diverse technologies, including dozens of pharmaceutical cases as well as biotechnology and life sciences cases.  In the pharmaceutical area, we are focused on bringing our many years of experience to the representation of generic pharmaceutical companies in ANDA cases.

The Pharmaceutical and Life Sciences Practice leverages the success of Alberti Lim in the patent space. More broadly, in patent litigation, a report by Patexia recognized the firm among the 50 best performing and most active law firms in the country representing plaintiffs and selected our lead counsel partner as among the best 30 patent litigation attorneys in the country in year 2023. More about our Pharmaceutical and Life Sciences practice can be found here:  https://www.albertilim.com/pharma-and-life-sciences/

About Alberti Lim & Tonkovich LLP

Founded in 2010 and based in Silicon Valley with attorneys in New York, Washington, D.C., and Austin, Texas, Alberti Lim has risen to become a highly sought-after patent litigation firm representing patent owners in large complex cases. With a team of 20 technically trained and experienced patent litigation trial attorneys representing an unrivaled assembly of specialized expertise, Alberti Lim is positioned as a firm of choice for plaintiffs seeking large recoveries in patent monetization and clients in need of objective-based IP solutions.

For more on Alberti Lim please visit www.albertilim.com

David Alberti | 650.825.4300